Article Details
Retrieved on: 2022-11-14 06:52:50
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
EQS-News: MorphoSys AG / Key word(s): Study resultsMorphoSys' Licensing Partner Roche Provides Update on Phase 3 GRADUATE Program for Gantenerumab ...
Article found on: www.pharmiweb.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here